GlassScriptPhysician profile
Melissa L Ricci
NPI 1598117350
$46,337.44
in general payments reported to CMS, 2019-2025
33 companies · $38K in 2025
The $38K reported for 2025 was more than what 99% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,196 · 2020: $214 · 2021: $929 · 2022: $2,518 · 2023: $1,039 · 2024: $966 · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $38K · Food and Beverage: $2,774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $37,707.50 |
| Food and Beverage | $2,773.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $37,947.19 | 2023-2025 | |
| Smith+Nephew, INC. | $1,696.10 | 2019-2025 | Grafix Pl, Collagenase Santyl, Stravix |
| Triad Life Sciences INC. | $1,535.57 | 2022 | |
| Paratek Pharmaceuticals, INC. | $662.03 | 2020-2025 | Nuzyra |
| Treace Medical Concepts, INC. | $630.73 | 2019-2021 | |
| Stryker Corporation | $427.80 | 2019-2022 | |
| Organogenesis INC. | $357.05 | 2020-2025 | Puraply, Simplimax |
| Amgen INC. | $331.52 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $306.26 | 2020-2023 | Krystexxa |
| Wright Medical Technology, INC. | $301.88 | 2019 | |
| Kci USA, INC. | $288.42 | 2019 | |
| Zimmer Biomet Holdings, INC. | $244.90 | 2019-2021 | |
| Bioventus LLC | $203.42 | 2019-2022 | |
| Averitas Pharma INC. | $149.68 | 2023-2024 | Qutenza |
| Trilliant Surgical LLC. | $134.21 | 2023 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, 12mm Htr Implant System, Non-Sterile |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $133.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cardiovascular Systems INC. | $122.76 | 2019 | |
| Misonix INC | $116.07 | 2021 | |
| Osteomed LLC | $113.06 | 2019 | |
| Derma Sciences, INC. | $90.61 | 2019 | |
| Ossio INC | $79.35 | 2019 | |
| Integra Lifesciences Corporation | $78.57 | 2019 | |
| Baxter Healthcare | $72.15 | 2019 | |
| Boston Scientific Corporation | $66.80 | 2024 | |
| Mallinckrodt Enterprises LLC | $66.22 | 2019 | |
| Baudax Bio INC. | $62.87 | 2021 | |
| Globus Medical, INC. | $31.24 | 2025 | Senza |
| Alfasigma USA, INC. | $18.57 | 2021 | |
| Orthofix Medical, INC. | $16.57 | 2022-2025 | Physio-Stim |
| Biowound Solutions, INC. | $15.49 | 2025 | Bio-Connekt |
| Celularity INC. | $14.00 | 2019 | |
| Djo, LLC | $13.24 | 2024 | Dr Comfort |
| Amniox Medical, INC. | $9.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Ricci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.